Skip to main content

Table 3 Factors associated with the occurrence of VAP (univariate and multivariate analysis)

From: Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves

ICU management

Ventilated patients (n = 282)

No VAP (n = 115)

VAP (n = 167)

p-value

Multivariate OR (95%IC), p-value

Curarisation, days, median (Q1;Q3)

2 (1;6)

1 (1;3)

4 (2;7)

< 0.001

-

Prone position, n (%)

162 (57%)

46 (40%)

116 (69%)

< 0.001

-

MV, days, median (Q1;Q3)

9 (5;20.3)

5 (3;8)

16 (9;27.8)

< 0.001

1.12 (1.08;1.18), p < 0,001

Dexamethasone, n (%)

217 (77%)

74 (64%)

143 (86%)

< 0.001

2.97 (1.46;6.25), p = 0,003

  1. MV mechanical ventilation, VAP ventilated associated pneumonia